279 participants
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-07
- Start Date:
- 2017-12-16
- Completion:
- 2022-07-07
Conditions
- Hematological Malignancies
Interventions
- DRUG
No Results Yet